Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data

Background: Sarcomatoid differentiation/histology of renal cell carcinoma (sRCC) in patients with metastatic renal cell carcinoma (mRCC) is still underresearched in current therapy regimes. We aimed to evaluate the impact of sRCC on outcomes in patients with mRCC treated with tyrosine kinase inhibit...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Florian Janisch, Christina Kienapfel, Constantin Fühner, Thomas Klotzbücher, Phillip Marks, Tobias Hillemacher, Christian P. Meyer, Takehiro Iwata, Mehdi Kardoust Parizi, Guido Sauter, Margit Fisch, Shahrokh F. Shariat, Roland Dahlem, Michael Rink
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2021-11-01
Edice:	Frontiers in Surgery
Témata:	renal cell carcinoma tyrosine kinase inhibitors targeted therapy sarcomatoid histology therapy regime
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fsurg.2021.763271/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!